1. Home
  2. TLSA vs PETS Comparison

TLSA vs PETS Comparison

Compare TLSA & PETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TLSA
  • PETS
  • Stock Information
  • Founded
  • TLSA 2013
  • PETS 1996
  • Country
  • TLSA United Kingdom
  • PETS United States
  • Employees
  • TLSA N/A
  • PETS N/A
  • Industry
  • TLSA Biotechnology: Pharmaceutical Preparations
  • PETS Retail-Drug Stores and Proprietary Stores
  • Sector
  • TLSA Health Care
  • PETS Consumer Staples
  • Exchange
  • TLSA Nasdaq
  • PETS Nasdaq
  • Market Cap
  • TLSA 240.0M
  • PETS 57.8M
  • IPO Year
  • TLSA 2000
  • PETS N/A
  • Fundamental
  • Price
  • TLSA $1.88
  • PETS $2.58
  • Analyst Decision
  • TLSA
  • PETS Sell
  • Analyst Count
  • TLSA 0
  • PETS 1
  • Target Price
  • TLSA N/A
  • PETS $3.20
  • AVG Volume (30 Days)
  • TLSA 347.3K
  • PETS 101.8K
  • Earning Date
  • TLSA 05-06-2025
  • PETS 10-14-2025
  • Dividend Yield
  • TLSA N/A
  • PETS N/A
  • EPS Growth
  • TLSA N/A
  • PETS N/A
  • EPS
  • TLSA N/A
  • PETS N/A
  • Revenue
  • TLSA N/A
  • PETS $226,972,000.00
  • Revenue This Year
  • TLSA N/A
  • PETS N/A
  • Revenue Next Year
  • TLSA N/A
  • PETS $2.98
  • P/E Ratio
  • TLSA N/A
  • PETS N/A
  • Revenue Growth
  • TLSA N/A
  • PETS N/A
  • 52 Week Low
  • TLSA $0.63
  • PETS $2.42
  • 52 Week High
  • TLSA $2.60
  • PETS $6.85
  • Technical
  • Relative Strength Index (RSI)
  • TLSA 41.66
  • PETS 46.05
  • Support Level
  • TLSA $1.85
  • PETS $2.46
  • Resistance Level
  • TLSA $2.04
  • PETS $2.68
  • Average True Range (ATR)
  • TLSA 0.15
  • PETS 0.14
  • MACD
  • TLSA -0.02
  • PETS 0.01
  • Stochastic Oscillator
  • TLSA 3.85
  • PETS 29.41

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

About PETS PetMed Express Inc.

PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.

Share on Social Networks: